• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Human leukocyte integrin CD18 promoter directs low levels of expression of a mutated human CD4 reporter gene in leukocytes of transgenic mice.

作者信息

Kwiatkowski B A, Embree L J, Ritchie K A, Hickstein D D

机构信息

Medical Research Service, Seattle Veterans Affairs Medical Center, Washington 98108, USA.

出版信息

Biochem Biophys Res Commun. 1996 May 15;222(2):601-6. doi: 10.1006/bbrc.1996.0790.

DOI:10.1006/bbrc.1996.0790
PMID:8670251
Abstract

The human leukocyte integrin CD18 molecule exists on the leukocyte surface in heterodimeric complexes with individual CD11 subunits, which mediate important leukocyte adhesion reactions. The CD18 subunit is developmentally regulated with the highest levels present on mature leukocytes of all lineages. To identify the regulatory sequences responsible for the tissue- and stage-specific expression of the CD18 subunit, we used 3.5 kb of regulatory sequence upstream from the human CD18 gene transcription start site to drive expression of a modified human CD4 reporter gene in transgenic mice. Despite the inclusion of Sp1 and PU.1 sites in the construct, and the generation of founder lines possessing multiple copies of the transgene, the reporter gene was expressed in low levels in the leukocytes of the transgenic mice. These studies indicate that although PU.1 and Sp1 sites are required for CD18 promoter activity in vitro, additional regulatory regions appear to be required for high levels of copy number dependent expression in vivo.

摘要

相似文献

1
Human leukocyte integrin CD18 promoter directs low levels of expression of a mutated human CD4 reporter gene in leukocytes of transgenic mice.
Biochem Biophys Res Commun. 1996 May 15;222(2):601-6. doi: 10.1006/bbrc.1996.0790.
2
Transgenic pigs expressing human decay-accelerating factor regulated by porcine MCP gene promoter.由猪MCP基因启动子调控表达人衰变加速因子的转基因猪。
Mol Reprod Dev. 2002 Mar;61(3):302-11. doi: 10.1002/mrd.10043.
3
Leukocyte integrin CD11b promoter directs expression in lymphocytes and granulocytes in transgenic mice.白细胞整合素CD11b启动子在转基因小鼠的淋巴细胞和粒细胞中指导表达。
Blood. 1995 Feb 15;85(4):1017-24.
4
Cloning and molecular dissection of the 8.8 kb pig uroplakin II promoter using transgenic mice and RT4 cells.利用转基因小鼠和RT4细胞对8.8 kb猪uroplakin II启动子进行克隆及分子剖析。
J Cell Biochem. 2006 Oct 1;99(2):462-77. doi: 10.1002/jcb.20931.
5
The human leukocyte integrin CD11a promoter directs expression in leukocytes of transgenic mice.人类白细胞整合素CD11a启动子指导转基因小鼠白细胞中的表达。
Blood. 1995 Jul 1;86(1):147-55.
6
An intronic silencer regulates B lymphocyte cell- and stage-specific expression of the human complement receptor type 2 (CR2, CD21) gene.一个内含子沉默子调节人类补体受体2(CR2,CD21)基因在B淋巴细胞中的细胞及阶段特异性表达。
J Immunol. 1998 Feb 1;160(3):1268-78.
7
Dominant-negative effect of the lymphocyte function-associated antigen-1 beta (CD18) cytoplasmic domain on leukocyte adhesion to ICAM-1 and fibronectin.淋巴细胞功能相关抗原-1β(CD18)胞质结构域对白细胞黏附于细胞间黏附分子-1(ICAM-1)和纤连蛋白的显性负效应。
J Immunol. 1998 Apr 1;160(7):3494-501.
8
PU.1/Spi-1 is essential for the B cell-specific activity of the mouse CD72 promoter.PU.1/Spi-1对于小鼠CD72启动子的B细胞特异性活性至关重要。
J Immunol. 1998 Mar 1;160(5):2287-96.
9
The ITGB2 immunomodulatory gene (CD18), enterocolitis, and Hirschsprung's disease.整合素β2免疫调节基因(CD18)、小肠结肠炎和先天性巨结肠病。
J Pediatr Surg. 2008 Aug;43(8):1439-44. doi: 10.1016/j.jpedsurg.2007.12.057.
10
Gene targeting yields a CD18-mutant mouse for study of inflammation.基因打靶技术培育出一种用于炎症研究的CD18突变小鼠。
J Immunol. 1993 Aug 1;151(3):1571-8.

引用本文的文献

1
Studies on transcriptional regulation of the mucosal T-cell integrin alphaEbeta7 (CD103).黏膜T细胞整合素αEβ7(CD103)转录调控的研究
Immunology. 2001 Jun;103(2):146-54. doi: 10.1046/j.1365-2567.2001.01232.x.